Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.

@article{Schottenfeld2018AtomoxetineFA,
  title={Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.},
  author={Richard S Schottenfeld and Marek C. Chawarski and Mehmet Alper Sofuoglu and Weng-Tink Chooi and Norzarina Mohd Zaharim and M Azhar M Yasin and Imran Ahmad and Sharifah Zubaidiah Syed Jaapar and Balasingam K Vicknasingam},
  journal={Drug and alcohol dependence},
  year={2018},
  volume={186},
  pages={
          130-137
        }
}
BACKGROUND Amphetamine type stimulants (ATS) use is highly prevalent and frequently co-occurs with opioid dependence in Malaysia and Asian countries. No medications have established efficacy for treating ATS use disorder. This study evaluated the safety, tolerability, and potential efficacy of atomoxetine for treating ATS use disorder. METHODS Participants with opioid and ATS dependence (N = 69) were enrolled in a pilot, double-blind, placebo-controlled randomized clinical trial; all received… CONTINUE READING
2
Twitter Mentions